HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Riedl, M. A. Articles by Diaz-Sanchez, D. Search for Related Content PubMed PubMed Citation Articles by Riedl, M. A. Articles by Diaz-Sanchez, D.

Initial High-Dose Nasal Allergen Exposure Prevents Allergic Sensitization to a Neoantigen¹

Marc A. Riedl^2,*, Elliot M. Landaw, Andrew Saxon^* and David Diaz-Sanchez^*

^* Hart and Louis Lyon Laboratory, Division of Clinical Immunology and Allergy, Department of Medicine, and Department of Biomathematics, David Geffen School of Medicine, University of California, Los Angeles, CA 90095

Primary allergic sensitization—IgE formation after Ag exposure—is fundamental in the development of allergic respiratory disease. With the rising prevalence of asthma and allergic rhinitis, improved understanding of the determining factors for allergic sensitization is needed. Human epidemiologic studies suggest high-dose allergen exposure may paradoxically protect against sensitization. Prospective human studies of allergen dose effect on primary allergic sensitization are lacking. We prospectively examined the effect of respiratory Ag dose exposure on the rate of primary allergic sensitization to a neoantigen, keyhole limpet hemocyanin, using a unique model of human nasal allergic sensitization. Atopic human subjects were exposed to 0.1-, 10-, 1,000-, or 100,000-µg doses of intranasal keyhole limpet hemocyanin in conjunction with adjuvant intranasal diesel exhaust particles. Ag-specific IgE, IgG, and IgG4 were measured in nasal lavage samples at the conclusion of the sensitization protocol. Allergic sensitization rates for the 0.1-, 10-, 1,000-, and 100,000-µg dose groups were 0, 100, 57, and 11%, respectively. All subjects produced Ag-specific IgG with the highest levels observed in the high-dose group. These results provide direct evidence that primary allergic sensitization may be prevented by initial high levels of respiratory Ag exposure through induction of a modified, nonallergic immune response. This Ag dose effect was capable of overcoming the well-established allergic adjuvant effects of diesel exhaust particle exposure. Whether this immune response represents durable allergic tolerance is not yet known. Studies investigating the molecular mechanisms of this non-IgE response may be useful in developing therapy to prevent allergic sensitization.

This article has been cited by other articles:

				T. Doi, K. Obayashi, T. Kadowaki, H. Fujii, and S. Koyasu PI3K is a negative regulator of IgE production Int. Immunol., April 1, 2008; 20(4): 499 - 508. [Abstract] [Full Text] [PDF]

				H. Sharma and E. Matsui Initial High-Dose Nasal Allergen Exposure Prevents Allergic Sensitization to a Neoantigen Pediatrics, August 1, 2006; 118(Supplement_1): S12 - S12. [Abstract] [PDF]